Why use recombinant Insulin in DoE for your media development?

Why use recombinant Insulin in DoE for your media development?

On October 6-7 we will make our debut at Cell Series UK virtual conferences. We are contributing to the Cell Culture and Bioprocessing conference track on Cell Media with the presentation: Why Use Recombinant Insulin in DoE For Your Media Development.

The presentation will feature a case study by the University of Barcelona based on the use of a DOE model for determining optimal levels of nutrients in cell culture media for CHO-S cells. We will as well as examine the use of human insulin in association with CHO cells to produce mabs and also with HEK-293 cells to replicate influenza virus antigens for vaccines.

If you are not attending Cell Series UK, but still would like to see the presentation, please contact us here.

Tuesday 29.09.2020